Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.

Abstract

BACKGROUND:

Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare neuroendocrine tumors releasing catecholamines. Metastatic pheochromocytomas/paragangliomas (PPGLs) occur in about 5-26% of cases. To date, the management of patients affected by metastatic disease is a challenge in the absence of guidelines.

AIM:

The aim of this study was to evaluate the overall survival (OS) and the progression-free survival (PFS) in metastatic PPGLs.

METHODS:

Clinical data of 20 patients referred to the Careggi University Hospital (Florence, Italy) were retrospectively collected. Follow-up ranged from 1989 to 2019. Site and size of primary tumor, biochemical activity, genetic analysis and employed therapies were considered. Data were analyzed with SPSS version 27.

RESULTS:

Nine PHEOs (45%) and 11 PGLs (55%) were enrolled. Median age at diagnosis was 43.5 years [30-55]. Mean follow-up was 104.6 ± 89.3 months. Catecholamines were released in 70% of cases. An inherited disease was reported in 50% of patients. OS from the initial diagnosis (OSpt) and from the metastatic appearance (OSmtx) were lower in older patients (OSpt p = 0.028; OSmtx p < 0.001), abdominal PGLs (OSpt p = 0.007; OSmtx p = 0.041), larger tumors (OSpt p = 0.008; OSmtx p = 0.025) and sporadic disease (OSpt p = 0.013; OSmtx p = 0.008).

CONCLUSION:

Our data showed that older age at the initial diagnosis, sympathetic extra-adrenal localization, larger tumors and wild-type neoplasms are related to worse prognosis. Notably, the employed therapies do not seem to influence the survival of our patients. At present, effective treatments for metastatic PPGLs are missing and a multidisciplinary approach is indispensably required.

• Authors: G De Filpo, G Cantini, G Rastrelli, G Vannini, T Ercolino, M Luconi, M Mannelli, M Maggi, L Canu
• Journal: Journal of endocrinological investigation (J Endocrinol Invest) Vol. 45 Issue 1 Pg. 149-157 (Jan 2022) ISSN: 1720-8386 [Electronic] Italy
• PMID: 34227051 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s).

Topics

• Adrenal Gland Neoplasms (diagnosis, mortality, pathology, therapy)
• Adult
• Female
• Humans
• Italy (epidemiology)
• Male
• Middle Aged
• Neoplasm Metastasis
• Paraganglioma (diagnosis, mortality, pathology, therapy)
• Pheochromocytoma (diagnosis, mortality, pathology, therapy)
• Prognosis
• Retrospective Studies
• Survival Analysis
• Treatment Outcome
• Watchful Waiting (statistics & numerical data)